Can you help?

Job Opportunity In Berlin With Global AMR R&D Hub!

Dear All, The Global AMR R&D Hub is looking for Head of the Global AMR R&D Hub Secretariat! The position would be based in Berlin and some of the position highlights are: Strategic vision and planning for the Hub, taking into consideration the global AMR R&D policy landscape Prepare recommendations on key R&D investment gaps and advocates

Read More »

NIAID BAA To Support In Vitro Diagnostic Product Development

Dear All, Excitingly, NIAID has released a new BAA (Broad Agency Announcement) entitled “Diagnostics Pre-Clinical Services Program.” Similar to the prior BAA for support of biopharmaceutical product development, this new BAA for diagnostic devices seeks a group who can manage a “multiple award Indefinite Delivery/Indefinite Quantity (IDIQ) type contract” (read that slowly!) and through it offer a comprehensive

Read More »

WAAW! Must-Read Article, A Quiz, A Video, A Call to Action

Notes: Newsflash … BARDA have opened their long-running BAA-18-100-SOL-00003 to include support for antifungal agents. Search for “antifungal” in the posted .pdf to find the text. The first deadline for proposals is 15 Dec 2022 and further deadlines will doubtless follow: as shown on page 9, this BAA has offered 4 deadlines/year since 2018!  Dear All, In

Read More »

WHO Forming Task Force of Antimicrobial Resistance Survivors

Dear All, The WHO has announced a call for expressions of interests from AMR survivors and their caregivers to serve in the inaugural WHO Task Force of AMR Survivors! WHO are specifically looking for both (i) survivors of a drug-resistant infection and (ii) anyone who was a direct caregiver of such a patient. Their goal is

Read More »

A Nature Article, a PASTEUR Act Op-Ed, and a VERY Important Phone Number

Dear All, First, Nature published an excellent article entitled “The importance of antimicrobial resistance in medical mycology” by Gow et al. The first sentence of the introduction really packs a punch — “The age of antibiotics, spanning only 80 years, is now entering a period of progressive and widespread emergence of drug-resistant organisms that threaten to bring

Read More »

Support the FORWARD and PASTEUR Acts by signing a letter!

Dear All, I’ve written before about the FORWARD Act, a bill introduced last year into Congress with the goal of supporting research in to treatment of endemic fungal diseases with a particular focus on coccidioidomycosis (*). It’s easy to see how this bill and the PASTEUR Act are mutually supportive … both seek to build

Read More »

ICARS seeks Executive Director

Dear All, An interesting job listing for you today! The International Centre for Antimicrobial Resistance Solutions (ICARS) is looking for an Executive Director. You can see more details on their vacancies page but here are some important details direct from ICARS — ICARS now seeks to appoint its first Executive Director to lead the organisation through its next

Read More »

Can You Answer A 3-Question Survey About This Newsletter?

Dear All, Wellcome Trust has renewed their support of AMR.Solutions and, with that, I’d like to share with you a survey about this newsletter. There are 3 questions and an optional comment box for you to write any additional thoughts you may have about this newsletter. I personally found last year’s survey to be highly

Read More »

Preclinical pipeline overview / Help fund a movie about AMR!

Dear All: Two things today. First, Ursula Theuretzbacher, Miloje Savic, Christine Ardal, and Kevin Outterson have published in Nature Reviews Drug Discovery a brief but instructive snapshot of the global preclinical antibacterial pipeline. This report nicely complements the recent WHO analysis of the clinical pipeline that concluded that “the world is running out of antibiotics.” You’ll want to read the paper yourself (it’s

Read More »
Scroll to Top